Thomson Medical GroupFRA:3H5 EBITDA Margin % is 18.70% as of Dec. 2025, which is 33% below its 10-year median of 28.06. The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Thomson Medical Group ranks better than 59.13% on this metric.
Thomson Medical Group (FRA:3H5) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Thomson Medical Group EBITDA Margin % Related Terms
Thomson Medical Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Thomson Medical Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3H5 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Thomson Medical Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thomson Medical Group EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Thomson Medical Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Thomson Medical Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thomson Medical Group (FRA:3H5) has a EBITDA Margin % of 18.70% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Thomson Medical Group and its competitors. This is 33% below median its historical median of 28.06. According to the industry distribution chart, Thomson Medical Group ranks #273 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 40.9%.
Is Thomson Medical Group's EBITDA Margin % too high?
Thomson Medical Group's current EBITDA Margin % of 18.70% is 33% below median its 10-year median of 28.06. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Thomson Medical Group's value of 18.70% is 83.2% above this industry median. Based on the distribution chart, Thomson Medical Group ranks #273 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Thomson Medical Group's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Thomson Medical Group ranks #273 out of 668 companies for EBITDA Margin %. This puts Thomson Medical Group in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Thomson Medical Group's value of 18.70% is 83.2% above this benchmark. While the company's 10-year median is 28.06 vs. the industry median of 10.21, Thomson Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thomson Medical Group's current EBITDA Margin % of 18.70% is 83.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Thomson Medical Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thomson Medical Group's current EBITDA Margin % is 18.70%, which is 33% below median its own 10-year median of 28.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Thomson Medical Group (FRA:3H5) is currently considered Possible Value Trap. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 30% below its estimated fair value. The current EBITDA Margin % is 18.70%, which is 33% below median its 10-year median of 28.06 and 83.2% above the Healthcare Providers & Services industry median of 10.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current EBITDA Margin % is 18.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3H5 has been successfully added to your 